ArticleRMD open2025

Correction: Effectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.